IntelliBio (Biotech) is Diagnostic Equipment in China that focus on medical fields business. Founded in 2013. They cover business area such as developer, rapid genetic and microbial protein analysis instrument, various field, development, time, flight mass spectrometer, microfluidic, extensive technological support, disease control, medical field.
2013
( 11 years old in 2024 )
Medical Fields
-
Zone D, Building D2, Qingdao Industrial Technology Research Institute
17 Songyuan Road, High-Tech District
Qingdao, Shandong 266000
China
Private
developerrapid genetic and microbial protein analysis instrumentvarious fielddevelopmenttimeflight mass spectrometermicrofluidicextensive technological supportdisease controlmedical field
* We use standard office opening hours in near IntelliBio (Biotech)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
IntelliBio (Biotech) is Diagnostic Equipment business from China that founded in 2013 (11 years old in 2024), IntelliBio (Biotech) business is focusing on Medical Fields.
IntelliBio (Biotech) headquarter office and corporate office address is located in Zone D, Building D2, Qingdao Industrial Technology Research Institute 17 Songyuan Road, High-Tech District Qingdao, Shandong 266000 China.
IntelliBio (Biotech) was founded in China.
In 2024, IntelliBio (Biotech) is currently focus on medical fields sector.
Above is snippet of Google Trends for "medical fields" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with IntelliBio (Biotech), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.